IL33 and central nervous system cancer: Knockdown of IL-33 or ST2 in glioma cell lines suppresses proliferation, migration and invasion in vitro and reduces tumor formation in vivo in both rodent models of intracerebral glioma cell implantation and subcutaneous xenograft (82–84).